Local drug delivery of 0.5% azithromycin in the treatment of chronic periodontitis among smokers

Australian Dental Journal

Volumn 58, Issue 1, 2013, Pages 34-40

  Pradeep, A R ^a   Bajaj, P ^a   Agarwal, E ^a   Rao, N S ^a   Naik, S B ^a   Kalra, N ^a   Priyanaka, N ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Local antimicrobial therapy; Non surgical periodontal therapy; Smoking

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CHRONIC PERIODONTITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GEL; HUMAN; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHEMOTHERAPY, ADJUVANT; CHRONIC PERIODONTITIS; DENTAL SCALING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GELS; HUMANS; MALE; PERIODONTAL INDEX; ROOT PLANING; SMOKING; TREATMENT OUTCOME;

EID: 84876221910     PISSN: 00450421     EISSN: 18347819     Source Type: Journal    
DOI: 10.1111/adj.12019     Document Type: Article

References (50)

1. Armitage GC. Development of a classification system for peri-odontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Slots J. Subgingival microflora and periodontal disease. J Clin Periodontol 1979;6:351-352.
3. Moore WEC. Microbiology of periodontal disease. J Periodon-tal Res 1987;22:335-341.
4. Lindhe J, Nyman S. The effect of plaque control and surgical pocket elimination on the establishment and maintenance of periodontal health. A longitudinal study of periodontal therapy in cases of advanced disease. J Clin Periodontol 1975;2:67-79.
5. Hill RW, Ramfjord SP, Morrison EC, et al. Four types of peri-odontal treatment compared over two years. J Periodontol 1981;52:655-662.
6. Ramfjord SP, Caffesse RG, Morrison EC, et al. Four modalities of periodontal treatment compared over five years. J Periodon-tal Res 1987;22:222-223.
7. Caffesse RG, Sweeney PL, Smith BA. Scaling and root planing with and without periodontal flap surgery. J Clin Periodontol 1986;13:205-210.
8. Rabbani GM, Ash MM Jr, Caffesse RG. The effectiveness of subgingival scaling and root planing in calculus removal. J Periodontol 1981;52:119-123.
9. Heitz-Mayfield LJ. Systemic antibiotics in periodontal therapy. Aust Dent J 2009;54:S96-S101.
10. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29(Suppl 3):136-159.
11. Steinberg D, Friedman M, Soskolne A, Sela MN. A new degrad-able controlled release device for treatment of periodontal disease: in vitro release study. J Periodontol 1990;61:393-398.
12. McGuire MK, Nunn ME. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodon-tol 1999;70:49-56.
13. Johnson GK, Hill M. Cigarette smoking and the periodontal patient. J Periodontol 2004;75:196-209.
14. Costabel U, Bross KJ, Reuter C, Rü hle KH, Matthys H. Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 1986;90:39-44.
15. MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA. Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 1992;63:908-913.
16. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 1990;20:369-395.
17. Loesche WJ, Gusberti F, Mettraux G, Higgins T, Syed S. Relationship between oxygen tension and subgingival bacterial flora in untreated human periodontal pockets. Infect Immun 1983;42:659-667.
18. Venditto MA. Therapeutic considerations: lower respiratory tract infections in smokers. J Am Osteopath Assoc 1992;92: 897-900, 903-905.
19. Silverstein P. Smoking and wound healing. Am J Med 1992;93:22S-24S.
20. Hanes PJ, Schuster GS, Lubas S. Binding, uptake, and release of nicotine by human gingival fibroblasts. J Periodontol 1991;62: 147-152.
21. Kaldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK. Long-term evaluation of periodontal therapy: II. Incidence of sites breaking down. J Periodontol 1996;67:103-108.
22. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 2006;33:241-253.
23. Darby IB, Hodge PJ, Riggio MP, Kinane DF. Clinical and microbiological effect of scaling and root planing in smoker and non-smoker chronic and aggressive periodontitis patients. J Clin Periodontol 2005;32:200-206.
24. Tonetti MS, Pini-Prato G, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-234.
25. McDonald PJ, Pruul H. Phagocytic uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:828-833.
26. Schentag JJ, Ballow CH. Tissue directed pharmacokinetics. Am J Med 1991;91:5S-11S.
27. Peters DH, Friedel HA, McTavish D. Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992;44:750-799.
28. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomyce-temcomitans. Antimicrob Agents Chemother 1992;36:1241-1243.
29. Pajukanta R. In vitro antimicrobial susceptibility of Porphyro-monas gingivalis to azithromycin, a novel macrolide. Oral Microbiol Immunol 1993;8:325-326.
30. van Winkelhoff AJ, Herrera D, Winkel EG, Dellemijn-Kip-puw N, Vandenbroucke-Grauls CM, Sanz M. Antibiotic resistance in subgingival microflora in patients with adult periodontitis. A comparative survey between Spain and the Netherlands (in Dutch). Ned Tijdschr Tandheelkd 1999;106: 290-294.
31. Haffajee AD, Patel M, Socransky SS. Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol 2008;23:148-157.
32. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. J Clin Periodontol 2007; 34:243-253.
33. Oteo A, Herrera D, Figuero E, O'Connor A, Gonza′lez I, Sanz, M. Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodon-titis: a pilot study. J Clin Periodontol 2010;37:1005-1015.
34. Haas AN, de Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical Trial. J Clin Periodontol 2008;35:696-704.
35. Mascarenhas P, Gapski R, Al-Shammari K, Hill R, Sohren S, Fenno JC. Clinical response of azithromycin as an adjunct to nonsurgical periodontal therapy in smokers. J Periodontol 2005;76:426-436.
36. Yashima A, Gomi K, Maeda N, Arai T. One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Peri-odontol 2009;80:1406-1413.
37. Pradeep AR, Sagar SV, Daisy H. Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 2008;79:2125-2135.
38. Kamma JJ, Giannopoulou C, Vasdekis VGS, Mombelli A. Cytokine profile in gingival crevicular fluid of aggressive peri-odontitis: influence of smoking and stress. J Clin Periodontol 2004;31:894-902.
39. Quigley G, Hein J. Comparative cleansing efficiency of manual and power brushing. J Am Dent Assoc 1962;65:26-29.
40. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by chloromethyl analogue of vitamin C. J Periodontol 1970;41:41-43.
41. Mombelli A, van Oosten MA, Schurch E, Lang NP. The microbiota associated with successful or failing implants. Oral Microbiol Immunol 1987;2:145-151.
42. Shah NH, Railkar AS, Chen FC, Tarantino R, Kumar S, Murjani M. A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic coglycolic) acid (PLGA) copolymers. J Control Release 1993;27:139-147.
43. Bergstrom J, Preber H. Tobacco use as a risk factor. J Period-ontol 1994;65:545-550.
44. Pindborg JJ. Tobacco and gingivitis. I. Statistical examination of the significance of tobacco in the development of ulceromem-branous gingivitis and the formation of calculus. J Dent Res 1947;26:261-264.
45. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64:16-23.
46. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28: 377-388.
47. Dastoor SF, Travan S, Neiva RF, Rayburn LA, Giannobile WV, Wang HL. Effect of adjunctive azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: A pilot study. J Periodontol 2007;78:1887-1896.
48. Goodson JM, Hogan PE, Dunham SL. Clinical responses following periodontal treatment by local drug delivery. J Period-ontol 1985;56:81-87.
49. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis (Part 2-Controlled drug delivery). Eur J Prosthodont Restor Dent 1995;3:111-117.
50. Agarwal E, Pradeep AR, Bajaj P, Naik SB. Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of chronic peri-odontitis subjects among smokers-a randomized controlled clinical trial. J Periodontol 2012;83:1155-1163.